Bisacodyl 5mg

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Bisacodyl 5mg
Generic name
BISACODYL 5MG
Manufacturer
Allegiant Health
Product type
HUMAN OTC DRUG
SPL set ID
46a377f5-822b-496f-a73b-66d8f902680a
SPL ID
f9cf5e5e-55b8-4786-b5d8-c39319823011
Version
4
Effective date
2019-03-26
Source export date
2026-11-06
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/245ea1c0d730b312e4410f082201cbe2cb4d1936fa2918316b6ea631293cbeba/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 08:09:23
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if you are unable to swallow without chewing within 1 hour after taking an antacid or milk Ask a doctor before use if you have abdominal pain nausea vomiting noticed a sudden change in bowel habits that persists over a period of 2 weeks When using this product do not chew or crush tablets abdominal discomfort, faintness, and cramps may occur Stop use and ask a doctor if you need to use more than 1 week rectal bleeding or failure to have a bowel movement after use of a laxative. These may be signs of a serious condition. If pregnant or breast-feeding If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children Keep out of reach of children. In case of accidental overdose, get medical help or contact a doctor or Poison Control Center (1-800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.